EAM
ORIAW

Empery Asset Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Empery Asset Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5K Hold
39,700
– – 0.03% 78
2022
Q2 		$6K Sell
39,700
-300
-0.8% -$97 0.03% 68
2022
Q1 		$15K Hold
40,000
– – 0.07% 70
2021
Q4 		$46K Buy
+40,000
New +$41.8K 0.1% 56

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Empery Asset Management's ORIAW Position: Q3 2022 in Review

Empery Asset Management held its Orion Biotech Opportunities Corp. Warrant (ORIAW) position steady in Q3 2022 at 39,700 shares worth $5K. The position accounts for 0.03% of the portfolio, ranked #78.

Empery Asset Management first reported a position in ORIAW in Q4 2021 and has held it in 4 quarters since. The position peaked at $46K in Q4 2021. 31 funds tracked by Wall St. Rank hold ORIAW as of Q3 2022.

  • Empery Asset Management held 39,700 shares of Orion Biotech Opportunities Corp. Warrant worth $5K as of Q3 2022.
  • Empery Asset Management left its Orion Biotech Opportunities Corp. Warrant share count unchanged in Q3 2022.
  • Orion Biotech Opportunities Corp. Warrant made up 0.03% of Empery Asset Management's portfolio in Q3 2022, its #78 holding.
  • Empery Asset Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and has held it in 4 quarters since.
  • Empery Asset Management's Orion Biotech Opportunities Corp. Warrant position peaked at $46K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.